ABSTRACT
tals in emergency situations. Primary interventions are fully clinical symptom oriented since it is uncertain if patients will get a sepsis diagnosis. It is essential to remember that, even if patients receiving emergency services lack a sepsis diagnosis, many conditions such as hypovolemia, malnutrition, acute attack of chronic diseases, and acute kidney failure can cause "systemic inflammatory response syndrome" (SIRS). Patients with a SIRS diagnosis have a higher probability of subsequently receiving a sepsis or severe sepsis diagnosis. Thus, limitation or even prevention of etomidate use during emergency conditions should be reconsidered. We believe that in order to use the advantages etomidate offers, we must develop different usage strategies, or work on alternative induction agents. Midazolam and etomidate are two of the most common agents used during rapid sequence intubation. [7, 8] Etomidate has been favored over other induction agents like midazolam by many physicians during RSI, mainly because of its hemodynamic tolerance in unstable patients. [7] Midazolam has no depressant impact over the adrenal cortex and, in addition, has anti-inflammatory and anti-convulsive action. However, midazolam can cause hypotension. It also has a broad doseresponse relationship that makes dosing inconsistent. [2] In contrast, etomidate is used in inductions during RSI since it
INTRODUCTION
Endotracheal intubation is a common procedure performed in emergency departments. Emergency patients who require intubation also need an induction agent for rapid-sequence intubation (RSI). [1] Administration of etomidate is still controversial in RSI. Multiple studies evaluating a single induction dose of etomidate and its effect on adrenal dysfunction and mortality have reported that even a single dose of etomidate can create adrenal dysfunction. [1] [2] [3] [4] [5] [6] A period is needed to diagnose patients who arrive at hospiUlus Travma Acil Cerrahi Derg, September 2015, Vol. 21, No. 5
Meyancı Köksal et al. The effect of single dose etomidate during emergency intubation on hemodynamics and adrenal cortex allows for a rapid, smooth and hemodynamically stable intubation. [1, 2] The primary outcome of this study was to evaluate the effect of using steroid on the adrenal cortex prior to a single dose of etomidate. Our secondary outcome measure was to compare the effects of midazolam and etomidate on hemodynamics.
The study aimed to evaluate the effects of a single dose of etomidate and the use of methylprednisolone prior to etomidate during RSI on hemodynamics and cortisol levels.
MATERIALS AND METHODS

Patient Population and Study Design
This study is a prospective, randomized, clinical trial approved by the Istanbul University Cerrapasa Medical Faculty Ethics Committee. Informed consent was obtained from the families of the patients. Age, gender, height, weight, co-morbidity, diagnosis, and Glasgow come score values of all patients were recorded. "Acute Physiology and Chronic Health Evaluation II" (APACHE II) scores were evaluated from clinical data available after the first 24 hours of intensive care.
Patients excluded from the study were those with a medical history of steroid therapy (obtained from their family) before RSI, those younger than 18 years of age, those who were pregnant, those with an endocrine disease and sepsis and those who had cardiopulmonary arrest before arrival in hospital. For all patients who received emergency surgical department (all patients diagnosis were acute abdomen), an approximate 30 ml/kg IV bolus Isolyte S (Eczacıbaşı-Baxter, Turkey) was infused following the first hemodynamic measurements. Those with systolic arterial pressures lower than 90 mmHg were given 250 ml of 6% Hydroxyethyl (HES) 130/0.4 (Voluven, Fresenius Kabi, Germany). A target of 0.5 ml/kg/h was established for urinary output according to the early goal-directed therapy protocol. Patients who were not able to reach those targets and those who were in need of inotropic support prior to intubation (RSI) were excluded from the study.
Sixty patients were randomly divided into three groups (n=20). Randomization was achieved by computer.
Data Collection
Following randomization, and before intubation in the emergency department, blood samples were taken for cortisol measurements, and hemodynamic parameters (systolic-diastolic arterial pressure, mean arterial pressure, heart rate, SOFA score) were recorded.
Group I patients were intubated with a 0.3 mg/kg etomidate IV (Etomidate Lipuro, Braun, Germany) and a 1.2 mg/kg rocuronium IV (Esmeron, Organon, Belgium).
Group II patients were intubated with a 0.3 mg/kg etomidate IV and rocuronium 1.2 mg/kg IV following a 2 mg/kg methylprednisolone IV (Prednol, Mustafa Nevzat, Turkey) given 2-4 minutes before etomidate.
Group III patients were intubated with a 0.15 mg/kg midazolam [7] IV (Dormicum, Roche, France) and 1.2 mg/kg rocuronium IV. Figure 1 is a flow diagram of all patients intubated during the study period. The measurements (plasma cortisol level, systolic-diastolicmean blood pressures, heart rates, and SOFA score) were repeated at hours 4 and 24 of the study.
Cortisol Measurement Technique
Plasma cortisol measurements were taken by competitive immunoassay with the use of an electrochemiluminescence immunoassay (ECLIA: Roche, Mannheim, Germany). After the blood sample was centrifuged, using paramagnetic particle in the supernatant liquid and antibody bonding, antigens were removed by magnet and cortisol was measured in µg/dl with four different emissions.
Statistical Analysis
Data were expressed as the mean±standard deviation (SD). Sample sizes of 20, 20 and 20 were obtained from the three groups whose mean values were to be compared. The total sample of 60 subjects achieved 95% power to detect a difference of at least 10.00 using the "Tukey-Kramer" (Pairwise) multiple comparison test at a 0.05 significance level. Differences between groups were considered significant at p<0.05. When comparing the three groups, "one way ANOVA" was used for parameters showing normal distribution, and "Tukey HSD" was used as post-hoc test. When comparing numerical parameters showing abnormal distribution between groups, "Mann-Whitney U" test was used. In repetitive parameters showing normal distribution, "Variance Analysis" test was used, and in repetitive parameters showing non-normal distribution, "Friedman Variance Analysis" was used. In the comparison of categorical variables, crosstab statistics were used.
RESULTS
No significant difference was observed between the demographic data (Table 1) .
In within-group comparison, although systolic arterial pressure values decreased in Groups I and II at the 4 th hour, only the decrease in Group I was statistically significant (p=0.032). Systolic arterial pressure values decreased in all three groups by hour 24 compared to preinduction values (In Group I p=0.003, in Group II p=0.041 and in III p=0.038) ( Table 2 ).
In between group comparison, systolic arterial pressure values were significantly lower at the 4 th hour in Group I compared to Groups II (p=0.042) and III (p=0.009) and at the 24 th hour in Group I compared to Groups II (p=0.033) and III (p=0.021). No significant difference was observed between Groups II and III (Table 2 ).
In within-group comparison, 4 th and 24 th hour diastolic arterial pressure values of only Group I were significant compared to preinduction values (p=0.038 and p=0.031 respectively) ( Table 2 ).
In between-group comparison, diastolic arterial pressure values were significantly lower at 24 hours in Group I compared with Groups II and III (p=0.040 and p=0.027 respectively). No significant difference was observed between Groups II and III (Table 2 ).
In within-group comparison, a decrease in mean arterial pressure values at the 4 th hour was observed in Group I compared to initial values (p=0.046) ( observed in all three groups in mean arterial pressure values compared to initial values (p=0.007, p=0.035, and p=0.027, respectively) ( Table 3) .
In between-group comparison, mean arterial pressure values at 4 hours were higher in Groups II and III compared to Group I (p=0.034 and p=0.039, respectively). Mean arterial pressure values at 24 hours were higher in Groups II and III compared to Group I (p=0.009 and p=0.006, respectively). No significant difference was observed between Group II and III (Table 3 ).
In within-group comparison, heart rate values at 24 hours were significantly higher only in Group I compared to both preinduction and 4 th hour heart rate values (p=0.004 and p=0.006, respectively) ( Table 3) .
Meyancı Köksal et al. The effect of single dose etomidate during emergency intubation on hemodynamics and adrenal cortex In between-group comparison, heart rate values were significantly lower at the 4 th hour in Group I compared to Groups II and III (p=0.009 and p=0.004). Heart rate values were significantly higher at the 24 th hour in Group I compared to Groups II and III (p=0.005 and p=0.001). Both at 4 th and 24 th hours, Group II heart rate values were higher compared to Group III (p=0.031 and p=0.008, respectively) ( Table 3 ).
In within-group comparison, 4 th hour SOFA scores of Groups I and III were lower compared to initial values (p=0.025 and p=0.008, respectively). SOFA scores at 24 hours were lower in all three groups compared to initial values (p=0.002, p=0.009 and p=0.004, respectively) ( Table 4) .
In between-group comparison, Group III had lower SOFA scores at the 4 th hour compared to Groups I and II (p=0.032 and p=0.041, respectively) and at the 24 th hour compared to Groups I and II (p=0.039 and p=0.023, respectively) ( Table 4 ).
In within-group comparison, plasma cortisol levels at the 4 th hour were lower in all groups compared to preinduction values (p<0.001, p=0.021, p=0.043, respectively). Plasma cortisol levels at the 24 th hour were lower in Group I compared to initial values (p=0.013). There was an increase in the plasma cortisol levels of Groups II and III at the 24 th hour compared to initial values. Only in Group III was this increase statistically significant when compared with the preinduction values (p=0.008). Cortisol levels at the 24 th hour were higher compared to the 4 th hour cortisol levels in Group I (p=0.007) ( Table 4) .
In between-group comparison, plasma cortisol levels at the 4 th hour were lower in Group I compared to Groups II and III (p<0.001 and p<0.001, respectively). Plasma cortisol levels at the 24 th hour were lower in Group I compared to Groups II and III (p<0.001 and p=0.001, respectively). There was a significant difference in the 24 th hour values between Groups II and III (p=0.039) ( Table 4) . 
DISCUSSION
Etomidate is a hypnotic agent preferred in patients with poor general status as it enables emergency intubation while keeping hemodynamics relatively stable. [9] However, etomidate is also known to cause adrenal suppression because of its inhibition of 11ß-hydroxylase, the enzyme that converts 11ß-deoxycortisol to cortisol. [1] Studies have documented that decreased cortisol levels occur approximately 30 minutes after a single bolus dose of etomidate, with a suppression duration lasting as long as 24 hours. [1, 3, 10] Most patients in need of emergency intubation subsequently receive a diagnosis of severe sepsis or septic shock. Therefore, the use of etomidate in emergency intubations should be re-assessed, as there are ongoing studies, evaluating the relative decrease in the cortisol levels in septic patients.
Our aim in this study was to evaluate and compare the effects of three different regimens for RSI on hemodynamics and cortisol levels: regimens being either a single dose of etomidate, or a steroid followed by etomidate, or midazolam alone. The patients included in our study had intubation indications as a result of acute abdomen related acute respiratory failure, meaning they had at least one organ dysfunction. Included were also patients who might have possible sepsis or would have sepsis even though the initial laboratory values did not support it. Cortisol levels are relatively low in sepsis, which can lead to hemodynamic instability. [11] Therefore, especially in patients with septic shock, hydrocortisone use is recommended. [11] There are studies reporting that etomidate has low or even no impact over cortisol levels in septic shock patients already using steroids. [12] These findings suggest that steroid administration prior to etomidate use may prevent its depressant impact over cortisol.
Many authors report that the negative effects of etomidate on the adrenal cortex used during intubation are lower in patients using steroids for septic shock. [13, 14] To explore this connection, we administered 2 mg/kg methylprednisolone prior to the use of etomidate in patients scheduled to undergo RSI. We selected methylprednisolone, as hydrocortisone is expensive and difficult to obtain in our country. Methylprednisolone was given in a single bolus dose since we did not use etomidate in repeating doses. The timing of steroid use during etomidate administration, the dosage, and the steroid type can be further discussed and studied. We were only able to administer methylprednisolone 2-4 minutes before etomidate use as the intubation of patients included in our study was under emergency conditions.
The effect of etomidate on cortisol peaks in the first 4 hours. [3] Accordingly, the use of methylprednisolone immediately before administration of etomidate may be justified theoretically. Ray et al. [15] have suggested that existence of issues as vasopressor dependent hypotension and impaired cardiovascular status should also be taken into account besides the possibility of adrenal suppression when using etomidate in the critically ill patients. Jung et al. [13] have suggested for patients in septic shock treated with hydrocortisone that etomidate does not decrease life-threating complications following intubation, but when associated with hydrocortisone it also does not impair outcome. In the above studies, intubation has been achieved with etomidate in patients receiving steroids. Ray et al. [15] and Jung et al. [13] have both reported that etomidate does not cause adrenal insufficiency but also has no positive effect on life expectancy in patients receiving hydrocortisone before etomidate use.
We were not able to find any studies comparing hemodynamic parameters. In our study, although the 4 th and 24 th hour MAP values were lower in all groups compared to initial values, the decreases were clinically acceptable and did not cause any perfusion abnormality. Nonetheless, minimal change was observed in Group III where midazolam was used as an induction agent, and maximal change was observed in Group I where only etomidate was used. A reasonable explanation for this is the exclusion of patients not responding to fluid resuscitation, as well as those needing vasoactive or inotropic drugs. They were excluded, as we believed inclusion would have carried ethical issues. This is a limitation of our study. When heart rate values were evaluated, the changes in Groups II and III were within acceptable ranges but in Group I, tachycardia occurred at hour 24. We believe the reason Group I MAP values did not decrease under auto-regulation threshold is that tachycardia occurred as compensation.
Though ketamine has been discussed and favored as an alternative hypnotic to etomidate in recent years, [15] [16] [17] we chose not to use ketamine in our study because of its consequences in emergency patients with poor general status and fluidelectrolyte imbalances. Furthermore, it is difficult to get sufficient anamnesis from patients who need emergency intubation or from their relatives, which might result in overlooking histories of epilepsy, increased intracranial pressure or severe cardiac problems. The use of ketamine in patients with these histories can cause complications. [17, 18] Ketamine also causes an increase in salivation that can lead to laryngospasm and difficulty in the glottic view during RSI. In conclusion, administration of methylprednisolone 2-4 minutes before the use of etomidate can prevent adrenal insufficiency in patients undergoing rapid sequence intubation in emergencies.
More stable hemodynamics were demonstrated in the group that was administered with midazolam and in the group that received methylprednisolone before the use of etomidate.
We were not able to find similar studies where SOFA scores were compared. In our study, even though scores in all groups decreased at the 24 th hour, the most evident decrease was in Group III. As all our results confirmed, Group III where midazolam was used, was hemodynamically the most stable and had the highest cortisol levels.
Conclusion
Firstly, midazolam has a better clinical effect in terms of hemodynamics and cortisol levels and, secondly, methylprednisolone given minutes before etomidate can decrease or even prevent adrenal insufficiency. We opted for midazolam because it is a benzodiazepine that does not cause profound hypotension if used in moderate doses (0.15 mg/kg). [7] There are various studies reporting hypotension with midazolam. [19] [20] [21] [22] We did not encounter any hypotension periods during intubation in the midazolam group. On the contrary, we observed improved hemodynamics compared with the etomidate group. In addition, midazolam can be used in low induction doses as an alternative to etomidate. The difference of our results from other studies may be explained by the difference of demographic data of our patients.
We concluded that the administration of methylprednisolone minutes before the use of etomidate could prevent adrenal insufficiency in patients undergoing rapid sequence intubation in emergency situations. In addition, midazolam can be used in low induction doses as an alternative to etomidate.
